NASDAQ:ALT
Altimmune, Inc. Stock News
$8.01
-0.89 (-10.00%)
At Close: May 17, 2024
Altimmune: A COVID-19 Winner After All
11:21pm, Tuesday, 01'st Dec 2020
Share price has recently stumbled due to results of the leading vaccines. Vaccine development timeline is way behind the leading vaccines.
Altimmune (ALT) Files IND for Phase I Study on Coronavirus Vaccine
08:59am, Thursday, 26'th Nov 2020
Altimmune (ALT) files a regulatory application to begin a phase I study in the United States on AdCOVID, its intranasal COVID-19 vaccine candidate. Stock rises.
Simple, single-dose nasal spray offers greater ease and comfort of administration ; positioning AdCOVID as a differentiated vaccine candidate for adults and children
Altimmune to Present at Upcoming Virtual Investor Conferences
07:00am, Monday, 16'th Nov 2020
GAITHERSBURG, Md., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company advancing proprietary intranasal vaccines and peptide therapeutics for li
Altimmune, Inc. (ALT) CEO Vipin Garg on Q3 2020 Results - Earnings Call Transcript
01:20pm, Tuesday, 10'th Nov 2020
Altimmune, Inc. (ALT) CEO Vipin Garg on Q3 2020 Results - Earnings Call Transcript
Altimmune Takes Next Step With Its COVID-19 Intranasal Vaccine
12:18pm, Tuesday, 10'th Nov 2020
Altimmune Inc. (NASDAQ: ALT) stepped forward on Tuesday with its vaccine candidate for COVID-19.
Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19
01:00am, Tuesday, 10'th Nov 2020
AdCOVID , a Single-dose Intranasal Vaccine for COVID-19 is Designed to Generate a Broad Immune Response Against COVID-19 with the Unique Ability to Promote Nasal Mucosal Immunity
Altimmune Announces Third Quarter 2020 Financial Results and Provides a Business Update
04:05pm, Monday, 09'th Nov 2020
GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the three and nine months ended Se
Altimmune to Announce Third Quarter 2020 Financial Results on November 10
08:00am, Tuesday, 03'rd Nov 2020
GAITHERSBURG, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will release its third quarter 2020 financial re
Arena Wins Special Situations Manager of the Year at Alt Credit Fund Intelligence US Performance Awards 2020
12:00am, Thursday, 22'nd Oct 2020
Arena wins
Singles' Day Set To Propel Alibaba Higher (NYSE:BABA)
03:57pm, Monday, 19'th Oct 2020
Mainland and Hong Kong markets started the week bullish with the anticipation of positive policy developments from the Chinese president's tour of southern China.
Mid-Day Market Update: Gold Down 2%; Medigus Shares Spike Higher
12:00am, Tuesday, 13'th Oct 2020
Midway through trading Tuesday, the Dow traded down 0.25% to 28,766.88 while the NASDAQ rose 0.19% to 11,899.41. The S&P also fell, falling 0.28% to 3,524.36.
The U.S. has...
Seeking Yield With Safety
12:16pm, Monday, 12'th Oct 2020
Lipper categories with low risk and moderate to high yields are listed. Top-ranked funds within the categories are listed.
The Daily Biotech Pulse: Novavax Advances Vaccine, Marinus Gets Nod For Late-Stage Study, 3 IPOs
12:00am, Friday, 25'th Sep 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 24)
Beigene Ltd (NASDAQ: BGNE...
India OTT Video Services Market, Competition, Forecast & Opportunities, 2026 - ResearchAndMarkets.com
12:00am, Thursday, 24'th Sep 2020
The
